Initial Indicators of the Public Health Impacts of Non-medical Cannabis Legalization in Canada
Overview
Affiliations
Reddon H, Lake S, Socias M, Hayashi K, DeBeck K, Walsh Z Int J Drug Policy. 2023; 119:104113.
PMID: 37481875 PMC: 10817207. DOI: 10.1016/j.drugpo.2023.104113.
Muller M, Meszaros E, Walter M, Baltes-Fluckiger L, Herdener M, Auer R Eur Addict Res. 2023; 29(3):213-221.
PMID: 37231849 PMC: 10389784. DOI: 10.1159/000530194.
Ahrens E, Wachtendorf L, Chiarella L, Ashrafian S, Suleiman A, Tartler T EClinicalMedicine. 2023; 57:101831.
PMID: 36798752 PMC: 9926083. DOI: 10.1016/j.eclinm.2023.101831.
Robertson K, Thyne M Prev Med Rep. 2022; 24:101639.
PMID: 34976690 PMC: 8683989. DOI: 10.1016/j.pmedr.2021.101639.
An overview of select cannabis use and supply indicators pre- and post-legalization in Canada.
Fischer B, Lee A, Robinson T, Hall W Subst Abuse Treat Prev Policy. 2021; 16(1):77.
PMID: 34620191 PMC: 8496143. DOI: 10.1186/s13011-021-00405-7.